The newly developed technique of retroviral-mediated gene transfer(RMGT ) which mainly involves the transfecting efficiency and safety aspects of RMGT were discussed.And the characteristics and effects of some exogenous genes which could be used to modify the immunogenicity of tumor cells were also classified and presented.Finally,the problems existed both in RMGT and in the preparation of genetically-engineered tumor cell vaccine were analysed.